Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Feb 13:11:11.
doi: 10.1186/1742-4682-11-11.

Modelling effects of internalized antibody: a simple comparative study

Affiliations
Comparative Study

Modelling effects of internalized antibody: a simple comparative study

Vladas Skakauskas et al. Theor Biol Med Model. .

Abstract

Background: The modelling framework is proposed to study protection properties of antibodies to neutralize the effects of the plant toxin (ricin). The present study extends our previous work by including (i) the model of intracellular transport of toxin to the Endoplasmic Reticulum and (ii) the model of the internalised antibodies (when antibody is delivered directly into the cytosol).

Method: Simulation of the receptor-toxin-antibody interaction is implemented by solving the systems of PDEs (advection-diffusion models) or ODEs (rate models) for the underlying transport coupled with mass-action kinetics.

Results: As the main application of the enhanced framework we present a comparative study of two kinds (external and internalised) of antibodies. This comparison is based on calculation of the non-dimensional protection factor using the same set of parameters (geometry, binding constants, initial concentrations of species, and total initial amount of the antibody).

Conclusion: This research will provide a framework for consistent evaluation and comparison of different types of antibodies for toxicological applications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The schematic diagram of receptor-toxin-antibody system: (a) - Scenario I and (b) - Scenario II. △ – toxin, ◇ – antibody, conglutinated △ and ◇ in circle – toxin-antibody complex, external sphere – cell membrane, internal sphere – ER envelope.
Figure 2
Figure 2
Influence of toxin diffusivity and absorption constant on antibody protection factor. (a) Scenario I. Solid and dashed lines correspond to value of uT determined for γ=0.1 and γ=0.05. Toxin diffusivity κT: 10-2 (1), 10-3 (2), 5·10-4 (3). (b) Scenario II. Absorption constant γ=0.1, toxin diffusivity κT: 10-2 (1), 5·10-4 (2). uA0,e=uA0,i=1 in cases (a) and (b).
Figure 3
Figure 3
Effect of variation of toxin diffusivity on parameter δ in caseuA0,e=1, uA0,i=4.87. Solid and dashed lines correspond to value of δ determined for γ=0.1 and γ=0.01. Toxin diffusivity κT: 10-2 (1), 10-3 (2), 5·10-4 (3).
Figure 4
Figure 4
Long-time asymptotic behavior of metric parameter δ(t). Solid and dashed lines correspond to δ determined for γ=0.1 and γ=0.01 in case uA0,e=uA0,i=1, κT=0.01.
Figure 5
Figure 5
Effect of variation of toxin diffusivity and absorption constant on parameter δ. Toxin diffusivity: (a)κT=10-4, (b)κT=10-3. Solid (uA0,e=uA0,i=1) and dashed (uA0,e=1, uA0,i=4.87) lines correspond to δ determined by advection-diffusion models, and bullets (uA0,e=uA0,i=1) and circles (uA0,e=1, uA0,i=4.87) to δ determined by well-mixed models for γ: 0.1 (1), 0.01 (2).
Figure 6
Figure 6
Effect of variation of toxin advection velocity v on parameterδ. Advection-diffusion models (solid lines): v=0.001, γ=0.01 (1), v=0.001, γ=0.1 (2), v=0.05, γ=0.01 (3), v=0.05, γ=0.1 (4); toxin diffusivity: (a)κT=10-3, (b)κT=10-4. Well-mixed models (dashed lines): γ=0.01 (1), γ=0.1 (2).

References

    1. Reisler BB, Smith LA. The need for continued development of ricin countermeasures. Adv Prev Med. 2012;2012:149737. - PMC - PubMed
    1. Prigent J, Panigai L, Lamourette P, Sauvaire D, Devilliers K, Plaisance M, Volland H, Créminon C, Simon S. Neutralising antibodies against ricin toxin. PLoS ONE. 2011;6:e20166. doi: 10.1371/journal.pone.0020166. - DOI - PMC - PubMed
    1. Pelat T, Avril A, Chahboun S, Mathieu J, Thullier P. Development of anti-toxins antibodies for biodefense. J Bioterr Biodef. 2011;S7:001.
    1. Song K, Mize RR, Marrero L, Corti M, Kirk JM, Pincus SH. Antibody to ricin A chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized. PLoS ONE. 2013;8:e62417. doi: 10.1371/journal.pone.0062417. - DOI - PMC - PubMed
    1. Skakauskas V, Katauskis P, Skvortsov A. A reaction-diffusion model of the receptor-toxin-antibody interaction. Theor Biol Med Model. 2011;8:32. doi: 10.1186/1742-4682-8-32. - DOI - PMC - PubMed

Publication types

LinkOut - more resources